Next-Generation Hemp Extracts and Compositions

Publication ID: 24-11857590_0005_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Hemp Extracts and Compositions,” Published Technical Disclosure No. 24-11857590_0005_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857590_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,590.

Summary of the Inventive Concept

A novel, AI-driven hemp extract production system that leverages machine learning, IoT, and blockchain technologies to create personalized, adaptive formulations, neuron-targeted therapeutics, and modular cultivation platforms, revolutionizing the hemp industry.

Background and Problem Solved

The original patent, 'Systems and methods for producing hemp extracts and compositions', provides a foundation for hemp extract production, but it has limitations in terms of customization, scalability, and therapeutic efficacy. The new inventive concept addresses these limitations by integrating cutting-edge technologies to create a more efficient, effective, and patient-centric approach.

Detailed Description of the Inventive Concept

The new inventive concept consists of four key components: 1) a database-driven system for generating personalized hemp extract formulations, 2) a CRISPR-Cas9 gene editing approach for enhancing CBD's neuroprotective effects, 3) a modular, AI-driven hemp cultivation platform with IoT-enabled grow modules and predictive analytics, and 4) a hemp-derived, bio-absorbable implantable device for sustained release of cannabinoids. These components work in tandem to create a seamless, data-driven production process that prioritizes patient needs and optimizes therapeutic outcomes.

Novelty and Inventive Step

The new inventive concept's integration of AI, IoT, blockchain, and gene editing technologies represents a significant departure from the original patent's methods. The use of machine learning algorithms to predict optimal extract compositions, CRISPR-Cas9 gene editing to enhance CBD's neuroprotective effects, and modular cultivation platforms with predictive analytics are all novel and non-obvious advancements that overcome the limitations of the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of other gene editing tools, such as TALEN or ZFN, or the integration of additional AI-powered modules for real-time quality control and supply chain management. Variations of the cultivation platform could incorporate different types of sensors or automation systems to optimize crop yields and reduce waste.

Potential Commercial Applications and Market

The new inventive concept has far-reaching commercial potential in the hemp industry, with applications in personalized medicine, pharmaceuticals, and nutraceuticals. The target market includes healthcare providers, pharmaceutical companies, and consumers seeking more effective and targeted hemp-based products.

CPC Classifications

SectionClassGroup
A A61 A61K36/185
A A61 A61K31/05
A A61 A61K2236/31
A A61 A61K2236/331
A A61 A61K2236/333
A A61 A61K2236/35
A A61 A61K2236/37
A A61 A61K2236/53
A A61 A61K2236/55

Original Patent Information

Patent NumberUS 11,857,590
TitleSystems and methods for producing hemp extracts and compositions
Assignee(s)Ecofibre Limited